Check-Cap Ltd. Ord (CHEK) 2.02 $CHEK Check-Cap to

New Post Public Reply Private Reply Replies (0) Message Board

Sep 22, 2016 at 9:02 AM

Check-Cap Ltd. Ord (CHEK) 2.02 $CHEK

Check-Cap to Present at the Rodman & Renshaw 18th Annual Global Investment Conference on September 13, 2016
PR Newswire - Wed Sep 07, 6:00AM CDT
Check-Cap Ltd. (Nasdaq: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that Bill Densel, Chief Executive Officer, will present at the Rodman & Renshaw 18th Annual Global Investment Conference on Tuesday, September 13, 2016 at 5:30pm ET in New York City.
CHEK: 2.02 (+0.07)

Check-Cap Reports Second Quarter 2016 Financial Results
PR Newswire - Mon Aug 15, 3:01PM CDT
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today provided a corporate update and announced its financial results for the second quarter and six months ended June 30, 2016.
CHEK: 2.02 (+0.07)

Check-Cap Ltd. Announces $5.9 Million Financing
PR Newswire - Mon Aug 08, 7:26AM CDT
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that it has entered into an agreement with a single health-care focused institutional investor for a registered direct placement of $5.9 million. The Securities Purchase Agreement provides for gross proceeds of $5.9 million, which is comprised of 643,614 ordinary shares, at a purchase price of $1.90 per share and 2,514,281 pre-funded warrants in lieu of ordinary shares, at a purchase price of $1.85 per warrant, which are exercisable for a nominal exercise price (approximately $0.05 per share). In the event that all warrants are exercised, the total gross proceeds to the Company for this financing would be $6.0 million.
CHEK: 2.02 (+0.07)

Check-Cap Announces Agreement with GE Healthcare for X-Ray Capsule Manufacturing Collaboration
PR Newswire - Thu Aug 04, 6:00AM CDT
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced it has entered into an agreement with GE Healthcare to develop and validate high-volume manufacturing for X-ray source production and assembly into Check-Cap's capsule. Upon successful completion, the parties may discuss collaboration on execution of a high-volume manufacturing facility and distribution of the Check-Cap system.
CHEK: 2.02 (+0.07)

Check-Cap Awarded $1.25 Million Grant for 2016 From Israel's Office of the Chief Scientist
PR Newswire - Tue Aug 02, 6:00AM CDT
Check-Cap Ltd. (the "Company" or "Check-Cap"

has awarded the Company a grant of NIS 4.8 million (approximately equivalent to $1.25 million based on the current exchange rate) for 2016. Charged with execution of government policy for support of R&D, the goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel's scientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally.
CHEK: 2.02 (+0.07)

A Win-Win With Check Into Cash: Cash for You and Cash for Kids
PR Newswire - Tue May 31, 11:46AM CDT
This month, don't miss Check Into Cash's Cash For Kids Facebook giveaway benefitting St. Jude Children's Research Hospital. Check Into Cash will match June's $500 giveaway prize with a $500 donation to St. Jude. St. Jude works to advance cures and prevention for pediatric catastrophic diseases, such as cancer, through research and treatment.
CHEK: 2.02 (+0.07)

Check-Cap Announces Preliminary Data Evaluating its Preparation-Free Colon Screening Capsule
PR Newswire - Wed May 25, 7:49AM CDT
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that preliminary data from pre-clinical and clinical studies were discussed in a podium presentation entitled "A Novel Preparation-Free X-Ray Imaging Capsule for Colon Cancer Screening" during Digestive Disease Week® (DDW) 2016, taking place in San Diego from May 21-24.
CHEK: 2.02 (+0.07)

Check-Cap Reports First Quarter 2016 Financial Results
PR Newswire - Thu May 19, 6:00AM CDT
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today provided a corporate update and announced its financial results for the three months ended March 31, 2016.
CHEK: 2.02 (+0.07)

Check-Cap Announces Presentation Evaluating Ingestible Capsule for Preparation-Free Colorectal Cancer Screening at Digestive Disease Week® 2016
PR Newswire - Tue May 17, 6:00AM CDT
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced a podium presentation entitled "A Novel Preparation-Free X-Ray Imaging Capsule for Colon Cancer Screening" will be delivered at Digestive Disease Week® (DDW) 2016. The conference is taking place in San Diego from May 21-24.
CHEK: 2.02 (+0.07)

Check-Cap Announces the Publication of Preliminary Clinical Data on its Preparation-Free Colon Screening Capsule in Gut
PR Newswire - Mon Dec 14, 6:00AM CST
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that data related to its clinical studies have been published in Gut, an official peer-reviewed journal of the British Society of Gastroenterology.
CHEK: 2.02 (+0.07)

Check-Cap CEO to Present at LD Micro Main Event on December 2, 2015
PR Newswire - Wed Nov 25, 6:00AM CST
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that Bill Densel, Check-Cap's Chief Executive Officer, will present at the LD Micro 8th Annual Main Event on December 2, 2015 in Los Angeles, CA.
CHEK: 2.02 (+0.07)

Bradley County's Official Halloween Goblin Returns for the 2015 Block Party
Marketwired - Mon Oct 26, 8:02AM CDT
As Halloween draws near, anticipation is building in Cleveland, Tenn. around the 28th annual Halloween Block Party and the spooky appearance of Tall Betsy, Bradley County's official Halloween goblin. Tall Betsy, a 7Â½-foot tall goblin rumored to reside in Fort Hill Cemetery, will make her appearance from 7:30-8 p.m. The Halloween Block Party takes place from 5-10 p.m. on Saturday, October 31 in downtown Cleveland.
CHEK: 2.02 (+0.07)

Check-Cap Featured at the World Endoscopy Organization Colorectal Cancer Screening Committee Meeting
PR Newswire - Mon Oct 26, 6:00AM CDT
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that the Check-Cap system was highlighted at the World Endoscopy Organization Colorectal Cancer Screening Committee (WEO CRC SC) Meeting which took place on October 23 in Barcelona, Spain.
CHEK: 2.02 (+0.07)

Check-Cap incurs lower net loss of USD48,000 for Q3 2015
M2 - Fri Oct 23, 5:43AM CDT
Medical diagnostics company Check-Cap (Nasdaq:CHEK)(Nasdaq:CHEKW) stated on Thursday its net loss of USD48,000 for the third quarter ended 30 September 2015.
CHEKW: 0.60 (-0.19), CHEK: 2.02 (+0.07)

Check-Cap Reports Third Quarter 2015 Financial Results
PR Newswire - Thu Oct 22, 6:00AM CDT
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced its financial results for the third quarter and nine months ended September 30, 2015. The Company also announced that it will hold its 2015 Annual General Meeting of Shareholders on December 1, 2015.
CHEK: 2.02 (+0.07)

Check-Cap Announces New Data Demonstrating Safety and Detection of Polyps in Clinical Study Evaluating Preparation-Free Colorectal Cancer Screening Capsule
PR Newswire - Tue Oct 20, 5:10AM CDT
Check-Cap Ltd. (Nasdaq: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced new data demonstrating safety and polyp detection from a clinical study evaluating the company's non-invasive system for preparation-free examination of the colon. Results will be presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting taking place October 16-21, 2015 and the United European Gastroenterology Week (UEGW) taking place October 24-28, 2015.
CHEK: 2.02 (+0.07)

Check Into Cash Launches #CheckIntoPink Campaign for Breast Cancer Awareness Month
Marketwired - Thu Oct 01, 6:01AM CDT
Check Into Cash, a national leader in alternative financial services, launches its #CheckIntoPink social campaign today to help spread knowledge about breast cancer. This is the second year in a row that Check Into Cash has participated in Breast Cancer Awareness Month to raise support for women's health. The campaign, which will run throughout October, will lead the audience to CheckIntoCash.com/GoPink, an informational page featuring tips and other educational resources.
CHEK: 2.02 (+0.07)

Check-Cap Announces Appointment of William Densel as Chief Executive Officer and Director
PR Newswire - Thu Aug 13, 8:30AM CDT
Check-Cap Ltd. (Nasdaq: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, announced today the appointment of William (Bill) Densel as Chief Executive Officer. The terms of Mr. Densel's engagement as Chief Executive Officer were approved at an extraordinary general meeting of shareholders held today. In addition, Check-Cap's Board of Directors elected Mr. Densel as a director to fill a vacancy on the Board, to serve in such office until the next annual general meeting of shareholders, effective as of the approval of the terms of his engagement as Chief Executive Officer by the Company's shareholders.
CHEK: 2.02 (+0.07)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Papa John's Faces Investor Lawsuit: Class Action Looms

Papa John's in Hot Water Again? Look, just when you think the pizza game is all dough and cheesy goodness, along comes a legal scuffle to toss our assumptions. Bronstein, Gewirtz & Grossman, LLC has slapped a class action lawsuit against Papa John's International, Inc. (NASDAQ: PZZA), claiming the company and some of its higher-ups haven't been playing fair with the...

Michigan Roof Inspections: Seasonal Insights That Count

Weather's Wrath and the Michigan Roof Here's the deal: Michigan doesn't mess around when it comes to weather. We're talking harsh winters with piles of snow, followed by muggy summers that toss storms like they're confetti. Keeping that roof in top shape isn't just some luxury; it’s a downright necessity. Gut-punch reality? Many ignore it until it's too late. That's...

AXIS-Y: Global Expansion Fueled by KRW 430B Valuation

Rewriting the Playbook in Global Skincare AXIS-Y decided to do things their way, not just because they could afford to, but because they believed in their vision. Their strategy defies the trends-driven tactics of this cutthroat beauty world. Instead, they’ve been all about climate-inspired products and vegan, cruelty-free standards. And now, after notching up some...

Nutromics Welcomes Plaxco: Strategic Tech Leap Forward

Professor Plaxco’s Dynamic Role at Nutromics Some folks start their day with breakfast and coffee, but Nutromics is grabbing headlines by introducing Professor Kevin Plaxco as the new Chief Scientific Officer. This strategic shift, made public on September 7, 2026, signals Nutromics’ ambition to amplify its DNA-based sensing footprint. As they gear up to launch their...

Coastal Property Realities: A Deep Dive into Ownership

Buying Coastal Property: A Balancing Act Ah, the dream of owning a piece of the beach in sunny South Florida. It sounds glamorous—something to brag about at the next family gathering. But let me tell you, diving into coastal property ownership isn't just about sipping cocktails by the ocean. It's about handling a fair share of headaches most folks don't anticipate....

NeuralTrust Expands to London as AI Risks Intensify

NeuralTrust's Strategic London Expansion In a world where AI agents are sprinting ahead of our security instincts, NeuralTrust makes a big play in the UK market, locking in their position with a new London office. This move isn't just about expansion—it's about tackling the tide of challenges head-on that comes with putting AI agents into the wild. London: A Hub for...

Early Orders Key for Custom Kids' Gifts This Season

Unwrap the Secret to Perfect Holiday Presents When it comes to giving the little ones something special for the holidays, the trick lies in timing. Not your run-of-the-mill timing, mind you—I'm talking about understanding how handcrafted, personalized toys can make or break the season. If you've ever scrambled for a last-minute gift, you know how that shaky feeling sets...

Stem Cell Market Set for Major Gains to 2031

Stem Cells: The Next Frontier or Hype? Folks, stem cells are no longer just a sci-fi concept tucked away in lab coats. This sector's set to boom from USD 18.9 billion in 2026 to a whopping USD 32.57 billion by 2031. Yeah, you heard it right, a solid 11.5% compound annual growth rate. Now, whether you're an investor or just keeping your finger on the biotech pulse, there's...

Ekinops and 1&1 Versatel Fuel a Connectivity Revolution

A European Partnership for Modern Connectivity Big players in the telecom industry are joining forces, and it's like watching a seasoned boxer find his perfect sparring partner. Today, Ekinops, a heavyweight in European connectivity, is shaking hands with 1&1 Versatel, a lead puncher in Germany's B2B communications. They're rolling out a unified connectivity portfolio...

DoorDash Speeds Up Gifting: Same-Day Delivery Wins

Transforming Urgent Gift-Giving with Local Delivery Ever found yourself scrambling for a last-minute gift when time seems to be slipping away? That's where DoorDash steps up, changing the game with their same-day delivery options. In the fast-paced world we're living in, folks aren't just leaning on DoorDash for takeout anymore. They're pushing it as a lifeline for...